Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
Cancer|May 2, 2013
Posterior reversible encephalopathy syndrome in neuroblastoma patients receiving anti-GD2 3F8 monoclonal antibodyBrian H Kushner, Shakeel Modak, Ellen M Basu, et al.
Cancer|September 7, 2012
Ifosfamide, carboplatin, and etoposide for neuroblastoma: a high-dose salvage regimen and review of the literatureBrian H Kushner, Shakeel Modak, Kim Kramer, et al.
Journal of Hematology & Oncology|November 27, 2025
Naxitamab plus stepped-up dosing of granulocyte-macrophage colony-stimulating factor for primary refractory high-risk neuroblastoma: results of a phase I/II trialBrian H Kushner, Shakeel Modak, Audrey Mauguen, et al.
Oncoimmunology|November 18, 2017
Phase I trial of anti-GD2 monoclonal antibody hu3F8 plus GM-CSF: Impact of body weight, immunogenicity and anti-GD2 response on pharmacokinetics and survivalIrene Y Cheung, Brian H Kushner, Shakeel Modak, et al.
International Journal of Cancer|February 11, 2026
A phase II trial of naxitamab plus stepped-up dosing of GM-CSF for patients with high-risk neuroblastoma in second or later complete remissionBrian H Kushner, Shakeel Modak, Charlie White, et al.
International Journal of Cancer|August 1, 2022
Immunotherapy with anti-GD2 monoclonal antibody in infants with high-risk neuroblastomaBrian H Kushner, Shakeel Modak, Kim Kramer, et al.
Pediatric Blood & Cancer|October 6, 2005
Acute graft-versus-host disease of the heartStephen S Roberts, Nicky Leeborg, Marc Loriaux, et al.
Pediatric Blood & Cancer|July 31, 2021
Association of BRAF V600E mutations with vasoactive intestinal peptide syndrome in MYCN-amplified neuroblastomaSanam Shahid, Brian H Kushner, Shakeel Modak, et al.
Pediatric Blood & Cancer|April 29, 2021
COVID-19 has changed the way we think about training future pediatric hematologists/oncologistsScott Moerdler, Bradley Gampel, Jennifer M Levine, et al.
JAMA Oncology|December 22, 2022
Effect of Oral β-Glucan on Antibody Response to Ganglioside Vaccine in Patients With High-Risk Neuroblastoma: A Phase 2 Randomized Clinical TrialIrene Y Cheung, Audrey Mauguen, Shakeel Modak, et al.
Pageof 6